NASDAQ:RXRX | Cash Flow Statement | RECURSION PHARMACEUTICALS, INC.

Complete source-backed cash-flow history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$131.01M
2026-03-31-$117.5M$19.67M-$81.1M$258,000.00-$338,000.00-$3.47M
2025-12-31-$108.12M$19.48M-$46.07M$1.24M-$1.24M$132.01M
2025-09-30-$162.25M
2025-06-30-$171.9M
2025-03-31-$202.49M$19.33M-$131.96M$1.83M-$7.27M$40.53M
2024-12-31-$178.91M$12.95M-$115.43M$1.3M$275.46M$10.64M
2024-09-30-$95.84M
2024-06-30-$97.54M
2024-03-31-$91.37M$7.38M-$102.3M$6.65M-$6.65M$13.9M
2023-12-31-$93M$7.55M-$74.08M$2.07M-$2.49M$80.66M
2023-09-30-$93.02M
2023-06-30-$76.73M
2023-03-31-$65.33M$3.73M-$73.32M$5.18M-$5.34M$1.92M
2022-12-31-$57.49M$3.21M-$44.75M$7.98M-$7.98M$147.26M
2022-09-30-$60.45M
2022-06-30-$65.56M
2022-03-31-$55.98M$2.77M$77.39M$4.34M$143.3M$2.08M
2021-12-31-$64.93M$2.24M-$61.16M$4.46M-$52.24M$3.8M
2021-09-30-$47.43M
2021-06-30-$43.4M
2021-03-31-$30.72M$1.4M-$30.76M$19.42M-$19.42M$2.13M
2020-12-31-$25.77M$1.13M$8.57M$3.69M-$4.59M$10.04M
2020-09-30-$23.87M
2020-06-30-$18.94M
2020-03-31-$18.42M$937,000.00-$17.82M$684,000.00-$684,000.00$6M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$644.76M$83.7M-$371.81M$6.47M-$16.87M$521.53M
2024-12-31-$463.66M$36.49M-$359.17M$13.7M$260.06M$304.12M
2023-12-31-$328.07M$24.4M-$287.78M$11.96M-$10.23M$140.13M
2022-12-31-$239.48M$11.76M-$83.52M$37.06M$193.25M$154.35M
2021-12-31-$186.48M$8.41M-$158.61M$39.8M-$271.74M$458.54M
2020-12-31-$87.01M$3.94M-$45.4M$5.83M-$8.74M$246.14M
2019-12-31-$61.88M$2.49M-$57.04M$3.91M-$3.91M$120.41M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.